Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 8, 2006, Pages 1845-1851

  Raj, Tina ^a   Kanellakis, Peter ^a   Pomilio, Giovanna ^a   Jennings, Garry ^a   Bobik, Alex ^a   Agrotis, Alex ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

ApoE mice; Atherosclerosis; Fibroblast growth factor receptors; Macrophage retention; Proliferation

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; APOLIPOPROTEIN E; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; CHEMOKINE; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE; PROTEIN TYROSINE KINASE; PYRROLE DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM HYPERPLASIA; INHIBITION KINETICS; INTIMA; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; ATHEROSCLEROSIS; DRUG ANTAGONISM; DRUG EFFECT; FAT INTAKE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MONOCYTE; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINES; DIETARY FATS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTORS; GLUCURONOSYLTRANSFERASE; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PYRROLES; RECEPTORS, FIBROBLAST GROWTH FACTOR; SINUS OF VALSALVA; TUNICA INTIMA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33746802496     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000227689.41288.5e     Document Type: Article

References (42)

1. Rauch BH, Millette E, Kenagy RD, Daum G, Fischer JW, Clowes AW. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem. 2005;280:17507-17511.
2. Tan EM, Levine E, Sorger T, Unger GA, Hacobian N, Planck B, Iozzo RV. Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells. Biochem Biophys Res Commun. 1989;163:84-92.
3. Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti P. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J. 2002;16:598-600.
4. Pakala R, Watanabe T, Benedict CR. Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc Radiat Med. 2002;3:95-101.
5. Tsuboi R, Sato Y, Rifkin DB. Correlation of cell migration, cell invasion, receptor number, proteinase production and basic fibroblast growth factor levels in endothelial cells. J Cell Biol. 1990;110:511-517.
6. Wong J, Rauhöft C, Dilley RJ, Agrotis A, Jennings GL, Bobik A. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation. Circulation. 1997;96:1631-1640.
7. Hughes SE, Crossman D, Hall PA. Expression of basic and acid fibroblast growth factors and their receptors in normal and atherosclerotic human arteries. Cardiovasc Res. 1993;27:1214-1219.
8. Wang JK, Goldfarb M. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors. Oncogene. 1997;14:1767-1778.
9. Ornitz DM, Xu J, Colvin JS, McEwan DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;271:15292-15297.
10. Tanghetti E, Ria R, Dell'Era P, Urbinati C, Rusnati M, Ennas MG, Presta M. Biological activity of substrate-bound basis fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. Oncogene. 2002;21:3889-3897.
11. Rauch BH, Millette E, Kenagy RD, Daum G, Clowes AW. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res. 2004;94:340-345.
12. Agrotis A, Kanellakis P, Kostolias G, DiVitto G, Wei C, Hannan R, Jennings G, Bobik A. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9. J Biol Chem. 2004;279:42221-42229.
13. Hughes SE. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Cardiovasc Res. 1996;32:557-569.
14. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BY, Hubbard SR, Schlessinger J. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science. 1997;276:955-960.
15. Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem. 2003;278:34226-34236.
16. Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem. 2005;280:20509-20515.
17. Ohmachi S, Mikami T, Konishi M, Miyake A, Itoh N. Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c. J Neurosci Res. 2003;72:436-443.
18. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627-1635.
19. Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res. 1999;84:323-328.
20. Cai Q, Lanting L, Natarajan R. Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol. 2004;287:C707-C714.
21. Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol. 2006;206:378-385.
22. Shimabukuro Y, Ichikawa T, Takayama S, Yamada S, Takedachi M, Terakura M, Hashikawa T, Murakami S. Fibroblast growth factor-2 regulates the synthesis of hyaluronan by human periodontal ligament cells. J Cell Physiol. 2005;203:557-563.
23. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, Yamaguchi Y, Rasmussen LM, Wogensen L. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res. 2005;96:583-591.
24. 2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. Biochem J. 1997;326:593-599.
25. Zohlnhöfer D, Nührenberg TG, Neuman F-J, Richter T, May AE, Schmidt RS, Denker K, Clauss MA, Schömig A, Baeuerle PA. Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties. Mol Pharmacol. 2004;65:880-889.
26. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002;16:870-879.
27. Prudovsky IA, Savion N, LaVallee TM, Maciag T. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of FGF receptor-1α isoforms but not the FGF receptor-1β isoforms. J Biol Chem. 1996;271:14198-14205.
28. Sakaguchi K, Lorenzi MV, Bottaro DP, Miki T. The acidic domain and first immunoglobulin-like loop of fibroblast growth factor receptor 2 modulate down stream signaling through glycosaminoglycan modification. Mol Cell Biol. 1999;19:6754-6764.
29. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:656-660.
30. Ito A, Shimokawa H, Fukumoto Y, Kadokami T, Nakaike R, Takayanagi T, Egashira K, Sueishi K, Takeshita A. The role of fibroblast growth factor-2 in the vascular effects of interleukin-1β in porcine coronary arteries in vivo. Cardiovasc Res. 1996;32:570-579.
31. Poon M, Hsu WC, Bogdanov VY, Taubman MB. Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am J Pathol. 1996;149:307-317.
32. Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, Takakura N, Nishikawa S, Nishikawa S-I, Kita T. Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation. 2001;103:2955-2960.
33. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res. 2005;96:172-179.
34. 1A receptor. Circulation. 2004;110:3849-3857.
35. Skaletz-Rorowski A, Pinkernell K, Sindermann JR, Schriever C, Müller JG, Eschert H, Breithardt G. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells. Basic Res Cardiol. 2004;99:272-278.
36. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan Z-Q, Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res. 2004;94:776-784.
37. Selzman CH, Shames BD, McIntyre RC Jr, Banerjee A, Harken AH. The NFκB inhibitory peptide, IκBα, prevents human vascular smooth muscle cell proliferation. Ann Thorac Surg. 1999;67:1227-1231.
38. Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ, Puré E. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular activation. J Clin Invest. 2001;108:1031-1040.
39. Braun M, Pietsch P, Schror K, Baumann G, Felix SB. Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res. 1999;41:395-401.
40. Schönbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol. 1999;155:1281-1291.
41. Moulton KS, Vakiili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo K-M, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003;100:4736-4741.
42. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2002;99:2234-2239.